Nanotag Biotechnologies GMBH

Göttingen, NDS

UEI
TLPKKTBS1GB8
CAGE
CN9L2
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Other Than One of the Proceeding
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
Rudolf-Wissell-Straße 28a, 37079 Göttingen, Germany
Website
nano-tag.com
Founded
2015
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Life Sciences Tools & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $0
FY2023 $98,869

Contract awards

Award Agency Obligated Awarded
Nanobody production against endocytic proteins 75N95023P00621 National Institute on Drug Abuse (NIH) $98,869

Quick answers

Is Nanotag Biotechnologies GMBH registered in SAM.gov?

Nanotag Biotechnologies GMBH's SAM.gov registration expired on October 17, 2026.

How much has Nanotag Biotechnologies GMBH received in federal contracts?

Federal contracts obligated $98,869 to Nanotag Biotechnologies GMBH in fiscal years 2023 through 2027.

What is Nanotag Biotechnologies GMBH's most recent federal award?

Nanotag Biotechnologies GMBH's most recent federal contract award is Nanobody production against endocytic proteins (75N95023P00621), from National Institute on Drug Abuse (NIH), on September 18, 2023.

On GovTribe

See Nanotag Biotechnologies GMBH's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors